Do you or someone you know have celiac disease?
Follow a gluten-free diet?
Still experiencing symptoms when exposed to gluten?
Interested in celiac research?
Alba Therapeutics is sponsoring a clinical trial locally for celiac disease.
The purpose of the research study is to look at how effective and safe an investigational medication is when it is given to subjects who have celiac disease.
The study will include people who have been diagnosed with celiac disease and have been on a gluten-free diet for 12 months or more before study entry.
You may qualify for the study if you:
Are between the ages of 18 and 75 and have been diagnosed with celiac disease
Have biopsy proven celiac disease and positive serology test results for 12 months or more before study entry
Have been on a gluten-free diet for 12 months or more before study entry
Are still experiencing symptoms when exposed to gluten
Have positive serum anti-tTG (IgA or IgG) or DGP (IgA or IgG) antibodies at screening
Are willing to maintain your current diet for the duration of the study
Satisfy other inclusion criteria
To participate in a survey to determine whether or not you qualify and to connect to a study site near you, go to www.celiacteam.com or call 855-423-5422.